Calliditas Therapeutics AB Sponsored ADR EPS - Earnings per Share 2020-2024 | CALT
Calliditas Therapeutics AB Sponsored ADR eps - earnings per share from 2020 to 2024. Eps - earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.
| Calliditas Therapeutics AB Sponsored ADR Annual EPS |
| 2023 |
$-1.64 |
| 2022 |
$-1.54 |
| 2021 |
$-2.30 |
| 2020 |
$-2.11 |
| 2019 |
$-0.19 |
| Calliditas Therapeutics AB Sponsored ADR Quarterly EPS |
| 2024-06-30 |
$-0.16 |
| 2024-03-31 |
$-0.88 |
| 2023-12-31 |
$-0.07 |
| 2023-09-30 |
$-0.58 |
| 2023-06-30 |
$-0.33 |
| 2023-03-31 |
$-0.67 |
| 2022-12-31 |
$0.07 |
| 2022-09-30 |
$-0.03 |
| 2022-06-30 |
$-0.74 |
| 2022-03-31 |
$-0.85 |
| 2021-12-31 |
$-0.98 |
| 2021-09-30 |
$0.05 |
| 2021-06-30 |
$-0.76 |
| 2021-03-31 |
$-0.60 |
| 2020-12-31 |
$-0.83 |
| 2020-09-30 |
$-0.63 |
| 2020-06-30 |
$-0.31 |
| 2020-03-31 |
$-0.34 |
| 2019-12-31 |
$-0.15 |
| 2019-09-30 |
$-0.27 |
| 2019-06-30 |
$0.50 |
| 2019-03-31 |
$-0.26 |
